Lupin partners with Fuji to strengthen women's health portfolio in Vietnam and Philippines
For marketing Nextstellis, a novel combination medication comprising of drospirenone (DRSP) and estetrol (E4) India-headquartered pharma major Lupin has signed a license and supply agreement with OLIC (Thailand), a subsidiary of Japanese pharmaceutical …